发明授权
- 专利标题： Compounds
- 专利标题（中）： 化合物
-
申请号： US13314574申请日： 2011-12-08
-
公开(公告)号： US08486968B2公开(公告)日： 2013-07-16
- 发明人: Henning Priepke , Henri Doods , Raimund Kuelzer , Roland Pfau , Dirk Stenkamp , Benjamin Pelcman , Robert Roenn , Dimitrijs Lubriks , Edgars Suna
- 申请人： Henning Priepke , Henri Doods , Raimund Kuelzer , Roland Pfau , Dirk Stenkamp , Benjamin Pelcman , Robert Roenn , Dimitrijs Lubriks , Edgars Suna
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim am Rhein
- 代理商 Michael P. Morris; Philip I. Datlow
- 优先权： EP10194459 20101210
- 主分类号： A01N43/42
- IPC分类号： A01N43/42 ; A61K31/44 ; A61K31/135 ; A01N33/18 ; A61K31/04
摘要：
This invention relates to compounds of formula I their use as inhibitors of the microsomal prostaglandin E2 synthase-1 (mPGES-1), pharmaceutical compositions containing them, and their use as medicaments for the treatment and/or prevention of inflammatory diseases and associated conditions. A, L, M, W, R1, R2, R3, R4, R6, R7, Ra, Rb have meanings given in the description.
公开/授权文献
- US20120309755A1 NOVEL COMPOUNDS 公开/授权日：2012-12-06
信息查询
IPC分类:
